This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

R1 RCM Dirección

Dirección controles de criterios 3/4

Información clave

Joe Flanagan

Chief Executive Officer (CEO)

US$15.8m

Compensación total

Porcentaje del salario del CEO	6.3%
Permanencia del CEO	6.2yrs
Participación del CEO	1.0%
Permanencia media de la dirección	4.9yrs
Promedio de permanencia en la Junta Directiva	5.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Joe Flanagan en comparación con los beneficios de R1 RCM?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2022	n/a	n/a	US$101m
Dec 31 2021	US$16m	US$1m	-US$495m
Sep 30 2021	n/a	n/a	-US$495m
Jun 30 2021	n/a	n/a	-US$512m
Mar 31 2021	n/a	n/a	-US$526m
Dec 31 2020	US$5m	US$895k	US$47m
Sep 30 2020	n/a	n/a	US$14m
Jun 30 2020	n/a	n/a	US$16m
Mar 31 2020	n/a	n/a	US$3m
Dec 31 2019	US$5m	US$820k	-US$9m
Sep 30 2019	n/a	n/a	-US$22m
Jun 30 2019	n/a	n/a	-US$42m
Mar 31 2019	n/a	n/a	-US$41m
Dec 31 2018	US$5m	US$595k	-US$64m
Sep 30 2018	n/a	n/a	-US$99m
Jun 30 2018	n/a	n/a	-US$88m
Mar 31 2018	n/a	n/a	-US$92m
Dec 31 2017	US$6m	US$595k	-US$76m
Sep 30 2017	n/a	n/a	-US$28m
Jun 30 2017	n/a	n/a	-US$3m
Mar 31 2017	n/a	n/a	-US$36m
Dec 31 2016	US$5m	US$595k	US$65m
Sep 30 2016	n/a	n/a	US$68m
Jun 30 2016	n/a	n/a	US$17m
Mar 31 2016	n/a	n/a	US$35m
Dec 31 2015	US$7m	US$595k	-US$84m

Compensación vs. Mercado: Joe's total compensation ($USD15.82M) is above average for companies of similar size in the German market ($USD3.09M).

Compensación vs. Ingresos: Joe's compensation has been consistent with company performance over the past year.

CEO

Joe Flanagan (50 yo)

6.2yrs

Permanencia

US$15,817,911

Compensación

Mr. Joseph Gerard Flanagan, also known as Joe, has been the Chief Executive Officer and President of R1 RCM Inc. (Former Name: Accretive Health, Inc.) since May 26, 2016 and April 21, 2016 respectively. Mr...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Joseph Flanagan	President	6.2yrs	US$15.82m	1.0% $ 78.4m
Rachel Wilson	Executive VP	2yrs	US$2.88m	0.0041% $ 325.3k
John Sparby	Executive VP of Operations & Delivery and COO	1.4yrs	US$2.34m	0.087% $ 6.8m
Gary Long	Executive VP & Chief Commercial Officer	4.8yrs	US$2.22m	0.081% $ 6.4m
Richard Evans	Senior VP	7.4yrs	US$672.53k	0% $ 0
Jay Sreedharan	Chief Technology & Digital Officer	less than a year	sin datos	sin datos
Atif Rahim	Senior Vice President of Investor Relations & Business Development	no data	sin datos	sin datos
Corey Perman	Executive Vice President of Compliance & Risk	5.8yrs	sin datos	sin datos
Sean Radcliffe	Executive VP	5.3yrs	sin datos	sin datos
Kate Sanderson	Executive VP & Chief Human Resources Officer	3.6yrs	sin datos	sin datos
Douglas Berkson	Senior Vice President	5.9yrs	sin datos	sin datos
Logan Johnston	Executive Vice President of Central Operations	4.9yrs	sin datos	sin datos

4.9yrs

Permanencia media

50yo

Promedio de edad

Equipo directivo experimentado: 6HL's management team is considered experienced (4.9 years average tenure).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Joseph Flanagan	President	6.1yrs	US$15.82m	1.0% $ 78.4m
Neal Moszkowski	Independent Director	6.3yrs	sin datos	sin datos
John Henneman	Lead Independent Director	6.3yrs	US$190.00k	0.020% $ 1.5m
Jill Smith	Independent Director	3.2yrs	US$215.00k	0.0095% $ 744.9k
Anthony Tersigni	Director	2.8yrs	US$190.00k	0.0090% $ 708.8k
Anthony Speranzo	Chairman of the Board	6.3yrs	US$190.00k	0.0090% $ 708.8k
David Dill	Director	1.2yrs	US$175.00k	0.0018% $ 144.6k
Ian Sacks	Independent Director	6.3yrs	sin datos	sin datos
Michael Feiner	Independent Director	5.3yrs	US$215.00k	0.015% $ 1.2m
Albert Zimmerli	Director	4.3yrs	sin datos	0.0080% $ 628.6k
Agnes Scanlan	Independent Director	less than a year	US$15.00k	sin datos

5.3yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: 6HL's board of directors are considered experienced (5.3 years average tenure).

This company listing is no longer active

R1 RCM Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

R1 RCM Inc. Announces Committee Changes

R1 RCM Inc. Appoints Three New Members to Its Board of Directors

R1 RCM Inc., Annual General Meeting, May 26, 2022

R1 RCM Inc. Informs the Leaving of Vijay Kotte, Its Executive Vice President, Strategy & Corporate Development and Chief Solutions Officer

R1 RCM Inc. Announces Board Changes

Lead Independent Director recently sold €3.1m worth of stock

Recent updates

R1 RCM Inc. to Report Q2, 2022 Results on Aug 03, 2022

New Mountain Capital Engages in Discussions with R1 RCM Inc

R1 RCM Inc. Revises Revenue Guidance for the Year 2022

R1 RCM Inc. Announces Committee Changes

R1 RCM Inc. Appoints Three New Members to Its Board of Directors

R1 RCM Inc. Provides Earnings Guidance for the Year 2022, 2023 and 2024

First quarter 2022 earnings released: EPS: US$0.10 (vs US$2.37 loss in 1Q 2021)

R1 RCM Inc. Provides Earnings Guidance on standalone basis for the Year 2022

R1 RCM Inc., Annual General Meeting, May 26, 2022

R1 RCM Inc. to Report Q1, 2022 Results on May 09, 2022

R1 RCM Inc. Informs the Leaving of Vijay Kotte, Its Executive Vice President, Strategy & Corporate Development and Chief Solutions Officer

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

R1 Rcm Inc. Provides Earnings Guidance for the Year 2022

R1 RCM Inc. Announces Board Changes

R1 RCM Inc. to Report Q4, 2021 Results on Feb 17, 2022

R1 RCM Inc. (NasdaqGS:RCM) entered into a definitive agreement to acquire Cloudmed from New Mountain Capital, L.L.C. and others for $4.1 billion.

Lead Independent Director recently sold €3.1m worth of stock

Third quarter 2021 earnings released: EPS US$0.061 (vs US$0.003 loss in 3Q 2020)

Independent Director recently bought €73k worth of stock

Independent Director recently bought €73k worth of stock

R1 RCM Inc. Raises Earnings Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$0.069 (vs US$0.042 in 2Q 2020)

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of VisitPay LLC.

R1 RCM Inc. has completed a Follow-on Equity Offering in the amount of $337.5 million.

First quarter 2021 earnings released: US$2.37 loss per share (vs US$0.058 profit in 1Q 2020)

R1 RCM Inc. (NasdaqGS:RCM) entered into a definitive agreement to acquire VisitPay LLC for approximately $300 million.

R1 RCM Inc. Provides Earnings Guidance for the Year 2021

Key Executive recently sold €2.1m worth of stock

Full year 2020 earnings released: EPS US$1.01 (vs US$0.078 loss in FY 2019)

Revenue beats expectations

New 90-day high: €24.12

R1 RCM Inc. to Report Q4, 2020 Results on Feb 18, 2021

New 90-day high: €21.19

R1 RCM Inc. Appoints John Sparby as Executive Vice President, Operations & Delivery and Chief Operating Officer

New 90-day high: €19.39

New 90-day high: €17.19

New 90-day high: €16.87

Revenue beats expectations

Third quarter 2020 earnings released: EPS US$0.045

New 90-day high: €15.33

LifePoint Health and R1 RCM Inc. Announce Partnership to Deliver Revenue Cycle Excellence and Enhance Patient Experience

New 90-day high: €15.05

EMpower Emergency Physicians and Integrated Care Physicians Select R1 RCM Inc. to Provide Revenue Cycle Management Services

New 90-day high: €14.49

New 90-day high - €13.57

New 90-day high - €12.73

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of Cerner RevWorks, LLC from Cerner Corporation (NasdaqGS:CERN).

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of SCI Solutions, Inc. from The Wicks Group of Companies, L.L.C. and others.

R1 RCM Inc. to Report Q2, 2020 Results on Aug 04, 2020

Sarnova, Inc. agreed to acquire Emergency Medical Services Business of R1 RCM Inc. (NasdaqGS:RCM) for approximately $140 million.

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad